Furthermore, since cancer stem-like cells have been found to be attractive targets for novel anticancer therapies [23, 24], the expression of CD133, a marker of these cancer stem-like cells [25, 26], in astrocytoma patients was also investigated. This evidence concerns the gene PROM1 and cancer.